Registering a steady increase for the 37th day in a row, the active cases have increased to 15,69,743, comprising 10.98 per cent of the total infections, while the national COVID-19 recovery rate dropped to 87.80 per cent.
The number of active cases remained below 5 lakh for the fifth consecutive day.
Registering a steady increase for the 35th day in a row, the active cases increased to 13,65,704, comprising 9.84 per cent of the total infections, while the national COVID-19 recovery rate has dropped to 88.92 per cent.
The comments of the Congress leader came after ICMR DG Balram Bhargava's letter to Bharat Biotech and principal investigators of medical colleges to complete the trial procedure of indigenous COVID-19 vaccine in a fast track method so that results of a clinical trial can be launched by August 15.
The most important finding of the study was that the Spike-protein neutralising antibodies found in the mixed vaccine groups were significantly higher than the same-vaccine groups, D Nageshwar Reddy, Chairman of AIG Hospitals said.
There is no scientific evidence so far to support the need for a booster vaccine dose against COVID-19, ICMR Director General Dr Balram Bhargava said on Monday underlining the completion of second dose for India's adult population is the priority for the government for now.
The death toll has climbed to 5,26,600 with 70 new fatalities, the data updated at 8 am stated.
Training his guns on Modi, he said, '(The) PM is silent. He has surrendered and is refusing to fight the pandemic.'
'Rahul inspired Indian industry with an ethos, an ethos of being more confident, more independent, more thorough, more competitive, more generous, more public-spirited, and more national and more international all at once,' remembers Naushad Forbes.
After identifying the man who was the patient zero or index case of the Nipah virus outbreak in Kerala, the state government on Saturday began looking for the source and place from where he got infected by seeking details of his mobile tower locations.
There are 12 sites across India, including private and public hospitals, conducting Phase 1 and 2 human clinical trials for Bharat Biotech's Covaxin. Based on an earlier letter by the Indian Council of Medical Research (ICMR) to the 12 sites, volunteer recruitments for the clinical trials were to begin by July 7. At least three sites are yet to kick-start the process.
The COVID-19 case fatality rate stood at 1.44 per cent.
Nearly eight months after the government repealed the three controversial farm Acts, it has constituted a high-powered panel under the chairmanship of former agriculture secretary Sanjay Agarwal to make the minimum support price (MSP) mechanism more effective and transparent as promised by Prime Minister Narendra Modi in his televised address announcing the repeal. The names of three members from the Samyukta Kisan Morcha (SKM), the main grouping that spearheaded the year-long agitation at Delhi's borders, have been withheld, pending receipt by the government, stated a gazette notification. NITI Aayog member Ramesh Chand, Indian Institute of Management-Ahmedabad Professor Sukhpal Singh, Indian Farmers Fertiliser Cooperative chairman Dilip Sanghani, secretaries of the Departments of Agriculture, Indian Council of Agricultural Research, Food and Consumer Affairs, Cooperation and Textiles, along with representatives from the state governments of Karnataka, Andhra Pradesh, Sikkim, and Odisha will also form part of the panel.
India's COVID-19 tally had crossed the 20-lakh mark on August 7, 30 lakh on August 23 and 40 lakh on September 5. It went past 50 lakh on September 16, 60 lakh on September 28 and crossed 70 lakh on October 11.
Lack of sleep, unhealthy eating habits, physical inactivity and a stressful daily schedule stemming from demanding career paths to juggling multiple hats on the personal front are some factors that increase health challenges, especially in young Indians, notes dietician Sheryl Salis.
Registering an increase for the 12th day in a row, the total active caseload has increased to 3,34,646, which now comprises 2.87 per cent of the total infections.
The number of people who have recuperated from the disease surged to 4,25,94,801. The case fatality rate stood at 1.22 per cent, it said.
Covaxin, a whole-virion inactivated SARS-CoV-2 vaccine used for mass immunization in the country, showed a 65.2 per cent protection against the Delta variant in a double-blind, randomized, multicentre, phase 3 clinical trial.
The phase 3 trial findings indicate that Covaxin induces a robust antibody response with no severe vaccine-related adverse events or deaths reported among the trial participants, the authors of the study said.
The country's active caseload increased to 2,10,544 and constitutes 1.85 per cent of the total infections. The recovery rate dropped to 96.75 per cent from 96.82 per cent on Saturday.
The total recoveries have surged to 58,27,704 while there are 9,02,425 active cases of coronavirus infection in the country.
In a video, Ramdev was allegedly heard saying, "Allopathy is a stupid science and medicines such as Remdesivir, Fabiflu, and other drugs approved by the Drugs Controller General of India have failed to treat COVID-19 patients." His remarks caused massive outrage and the IMA sent over a legal notice to him.
The death toll has climbed to 5,24,157 with 54 fatalities, the data updated at 8 am stated.
Vardhan said the ICMR is actively researching on reports of COVID-19 reinfection and although the number of such cases is negligible at this moment, the government is fully seized of the importance of the matter, the health ministry said in a statement.
The coronavirus caseload surged to 56,46,010, while the death toll climbed to 90,020 with 1,085 people succumbing to the disease in a span of 24 hours, the data updated at 8 am showed.
The ICMR said people having symptoms like fever, cough, sore throat and runny nose and residing in hotspots or cluster areas and in evacuee centres will now be tested for coronavirus infection.
The trial will take place in 525 subjects at various sites, including AIIMS, Delhi, AIIMS, Patna and Meditrina Institute of Medical Sciences, Nagpur.
The active cases constitute 0.05 per cent of the total infections.
The daily positivity rate was recorded at 0.98 per cent while the weekly figure was recorded at 0.76 per cent, the ministry said.
The active cases comprise 0.26 per cent of the total infections, while the national COVID-19 recovery rate was recorded at 98.53 per cent, the ministry said.
India has crossed the 3-crore mark in Covid-19 tests and its tests per million stand at 21,769. Where does that place India vis--vis other nations?
The death toll climbed to 5,25,242 with 19 new fatalities, the data updated at 8 am stated.
The health ministry said that 5,22,149 deaths have been reported so far in the country.
'Delta continues to be the dominant lineage for new cases across all parts of India in recent samples and remains the most rapidly rising lineage globally that is responsible for multiple outbreaks, including across Southeast Asia, which shows the fastest growth in new cases globally,' the INSACOG said.
Unanimously confirmed by the Senate last week, Panchanathan, 58, from the Arizona State University, replaces White House Office of Science and Technology Policy (OSTP) Director Dr Kelvin Droegemeier who served as Acting Director of the National Science Foundation (NSF).
The Theory of Evolution, proposed by the English naturalist, explains that all living beings evolved through natural selection, which favours inherited traits that improve an individual's ability to compete, survive, and reproduce.
The COVID-19 case fatality rate was recorded at 1.49 per cent.
The number of people who have recuperated from the disease surged to 86,04,955 pushing the national recovery rate to 93.76 per cent
The death toll climbed to 5,24,974 with 20 more fatalities, the data updated at 8 am stated.
There are 6,76,514 active cases of coronavirus infection in the country which is 24.45 per cent of the total caseload, while the number of recoveries has surged to 20,37,870.
